• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

B7-H3是人类T细胞活化的有效抑制剂:无证据表明B7-H3与TREML2相互作用。

B7-H3 is a potent inhibitor of human T-cell activation: No evidence for B7-H3 and TREML2 interaction.

作者信息

Leitner Judith, Klauser Christoph, Pickl Winfried F, Stöckl Johannes, Majdic Otto, Bardet Anaïs F, Kreil David P, Dong Chen, Yamazaki Tomohide, Zlabinger Gerhard, Pfistershammer Katharina, Steinberger Peter

机构信息

Institute of Immunology, Center of Physiology, Pathophysiology and Immunology, Medical University Vienna, Austria.

出版信息

Eur J Immunol. 2009 Jul;39(7):1754-64. doi: 10.1002/eji.200839028.

DOI:10.1002/eji.200839028
PMID:19544488
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2978551/
Abstract

B7-H3 belongs to the B7 superfamily, a group of molecules that costimulate or down-modulate T-cell responses. Although it was shown that B7-H3 could inhibit T-cell responses, several studies - most of them performed in murine systems - found B7-H3 to act in a costimulatory manner. In this study, we have specifically addressed a potential functional dualism of human B7-H3 by assessing the effect of this molecule under varying experimental conditions as well as on different T-cell subsets. We show that B7-H3 does not costimulate human T cells. In the presence of strong activating signals, B7-H3 potently and consistently down-modulated human T-cell responses. This inhibitory effect was evident when analysing proliferation and cytokine production and affected naïve as well as pre-activated T cells. Furthermore, we demonstrate that B7-H3-T-cell interaction is characterised by an early suppression of IL-2 and that T-cell inhibition can be reverted by exogenous IL-2. Since the triggering receptor expressed on myeloid cells like transcript 2 (TREML2/TLT-2) has been recently described as costimulatory receptor of murine B7-H3 we have extensively analysed interaction of human B7-H3 with TREML2/TLT-2. In these experiments we found no evidence for such an interaction. Furthermore, our data do not point to a role for murine TREML2 as a receptor for murine B7-H3.

摘要

B7-H3属于B7超家族,这是一组共刺激或下调T细胞反应的分子。虽然有研究表明B7-H3可抑制T细胞反应,但多项研究——其中大部分是在小鼠系统中进行的——发现B7-H3具有共刺激作用。在本研究中,我们通过评估该分子在不同实验条件下以及对不同T细胞亚群的作用,专门探讨了人B7-H3潜在的功能二元性。我们发现B7-H3不会共刺激人T细胞。在存在强激活信号的情况下,B7-H3能有效且持续地下调人T细胞反应。在分析增殖和细胞因子产生时,这种抑制作用很明显,且对初始T细胞以及预激活T细胞均有影响。此外,我们证明B7-H3与T细胞的相互作用以早期抑制白细胞介素-2为特征,并且外源性白细胞介素-2可逆转T细胞抑制。由于最近已将髓系细胞上表达的触发受体样转录本2(TREML2/TLT-2)描述为小鼠B7-H3的共刺激受体,我们广泛分析了人B7-H3与TREML2/TLT-2的相互作用。在这些实验中,我们没有发现这种相互作用的证据。此外,我们的数据也未表明小鼠TREML2作为小鼠B7-H3受体的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc6c/2978551/826c95d88b1b/ukmss-32622-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc6c/2978551/f0e69df61da4/ukmss-32622-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc6c/2978551/519d6271f56e/ukmss-32622-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc6c/2978551/7e59a9081709/ukmss-32622-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc6c/2978551/7de0ed2711bb/ukmss-32622-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc6c/2978551/3a201b8b7685/ukmss-32622-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc6c/2978551/4edae30cafb4/ukmss-32622-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc6c/2978551/826c95d88b1b/ukmss-32622-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc6c/2978551/f0e69df61da4/ukmss-32622-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc6c/2978551/519d6271f56e/ukmss-32622-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc6c/2978551/7e59a9081709/ukmss-32622-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc6c/2978551/7de0ed2711bb/ukmss-32622-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc6c/2978551/3a201b8b7685/ukmss-32622-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc6c/2978551/4edae30cafb4/ukmss-32622-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc6c/2978551/826c95d88b1b/ukmss-32622-f0007.jpg

相似文献

1
B7-H3 is a potent inhibitor of human T-cell activation: No evidence for B7-H3 and TREML2 interaction.B7-H3是人类T细胞活化的有效抑制剂:无证据表明B7-H3与TREML2相互作用。
Eur J Immunol. 2009 Jul;39(7):1754-64. doi: 10.1002/eji.200839028.
2
Enhancement of effector CD8+ T-cell function by tumour-associated B7-H3 and modulation of its counter-receptor triggering receptor expressed on myeloid cell-like transcript 2 at tumour sites.肿瘤相关 B7-H3 通过调节肿瘤部位髓样细胞样转录物 2 表达的触发受体增强效应 CD8+ T 细胞功能。
Immunology. 2010 Jul;130(3):363-73. doi: 10.1111/j.1365-2567.2009.03236.x. Epub 2010 Feb 5.
3
Triggering receptor expressed on myeloid cell-like transcript 2 (TLT-2) is a counter-receptor for B7-H3 and enhances T cell responses.髓样细胞样转录本2(TLT-2)上表达的触发受体是B7-H3的反受体,可增强T细胞反应。
Proc Natl Acad Sci U S A. 2008 Jul 29;105(30):10495-500. doi: 10.1073/pnas.0802423105. Epub 2008 Jul 23.
4
Murine b7-h3 is a co-stimulatory molecule for T cell activation.小鼠b7-h3是一种用于T细胞激活的共刺激分子。
Monoclon Antib Immunodiagn Immunother. 2013 Dec;32(6):395-8. doi: 10.1089/mab.2013.0052.
5
Molecular characterization of human 4Ig-B7-H3, a member of the B7 family with four Ig-like domains.人类4Ig-B7-H3的分子特征,B7家族中具有四个免疫球蛋白样结构域的成员。
J Immunol. 2004 Feb 15;172(4):2352-9. doi: 10.4049/jimmunol.172.4.2352.
6
B7-h3 and its role in antitumor immunity.B7-h3及其在抗肿瘤免疫中的作用。
Clin Dev Immunol. 2010;2010:683875. doi: 10.1155/2010/683875. Epub 2010 Nov 28.
7
Murine B7-H3 is a negative regulator of T cells.小鼠B7-H3是T细胞的负调节因子。
J Immunol. 2004 Aug 15;173(4):2500-6. doi: 10.4049/jimmunol.173.4.2500.
8
Interactions of T cells with fibroblast-like synoviocytes: role of the B7 family costimulatory ligand B7-H3.T细胞与成纤维样滑膜细胞的相互作用:共刺激配体B7-H3在B7家族中的作用
J Immunol. 2008 Mar 1;180(5):2989-98. doi: 10.4049/jimmunol.180.5.2989.
9
Fine tuning the immune response through B7-H3 and B7-H4.通过B7-H3和B7-H4微调免疫反应。
Immunol Rev. 2009 May;229(1):145-51. doi: 10.1111/j.1600-065X.2009.00768.x.
10
Activated human B lymphocytes express three CTLA-4 counterreceptors that costimulate T-cell activation.活化的人类B淋巴细胞表达三种共刺激T细胞活化的CTLA-4反受体。
Proc Natl Acad Sci U S A. 1993 Dec 1;90(23):11059-63. doi: 10.1073/pnas.90.23.11059.

引用本文的文献

1
Fc-optimized CD276 antibody enhances NK cell activation against non-small cell lung cancer.Fc优化的CD276抗体增强自然杀伤细胞对非小细胞肺癌的激活作用。
Front Immunol. 2025 Jul 31;16:1624751. doi: 10.3389/fimmu.2025.1624751. eCollection 2025.
2
B7-H3 in Cancer Immunotherapy-Prospects and Challenges: A Review of the Literature.癌症免疫治疗中的B7-H3:前景与挑战——文献综述
Cells. 2025 Aug 6;14(15):1209. doi: 10.3390/cells14151209.
3
Interplay Between the Epigenome, the Microenvironment, and the Immune System in Neuroblastoma.

本文引用的文献

1
The tumor microenvironment and its role in promoting tumor growth.肿瘤微环境及其在促进肿瘤生长中的作用。
Oncogene. 2008 Oct 6;27(45):5904-12. doi: 10.1038/onc.2008.271.
2
The capacity of the TNF family members 4-1BBL, OX40L, CD70, GITRL, CD30L and LIGHT to costimulate human T cells.肿瘤坏死因子家族成员4-1BBL、OX40L、CD70、GITRL、CD30L和LIGHT共刺激人T细胞的能力。
Eur J Immunol. 2008 Oct;38(10):2678-88. doi: 10.1002/eji.200838250.
3
Triggering receptor expressed on myeloid cell-like transcript 2 (TLT-2) is a counter-receptor for B7-H3 and enhances T cell responses.
神经母细胞瘤中表观基因组、微环境与免疫系统之间的相互作用
Cancers (Basel). 2025 May 29;17(11):1812. doi: 10.3390/cancers17111812.
4
B7H3 in Gastrointestinal Tumors: Role in Immune Modulation and Cancer Progression: A Review of the Literature.B7H3在胃肠道肿瘤中的作用:在免疫调节和癌症进展中的作用——文献综述
Cells. 2025 Apr 2;14(7):530. doi: 10.3390/cells14070530.
5
TREML2 enhances sensitivity of acute myeloid leukemia cells to chemotherapy by inhibiting the NF-κB/CXCL10 pathway.TREML2通过抑制NF-κB/CXCL10信号通路增强急性髓系白血病细胞对化疗的敏感性。
Blood Sci. 2025 Mar 18;7(2):e00223. doi: 10.1097/BS9.0000000000000223. eCollection 2025 Jun.
6
Identification of the B7-H3 Interaction Partners Using a Proximity Labeling Strategy.使用邻近标记策略鉴定B7-H3相互作用蛋白
Int J Mol Sci. 2025 Feb 18;26(4):1731. doi: 10.3390/ijms26041731.
7
Novel B7-H3 CAR T cells show potent antitumor effects in glioblastoma: a preclinical study.新型B7-H3嵌合抗原受体T细胞在胶质母细胞瘤中显示出强大的抗肿瘤作用:一项临床前研究。
J Immunother Cancer. 2025 Jan 25;13(1):e010083. doi: 10.1136/jitc-2024-010083.
8
A Pan-Cancer Analysis of the Oncogenic Role of CD276 in Human Tumors.CD276在人类肿瘤中致癌作用的泛癌分析
Genes (Basel). 2024 Nov 27;15(12):1527. doi: 10.3390/genes15121527.
9
Multiomic profiling of chronically activated CD4+ T cells identifies drivers of exhaustion and metabolic reprogramming.慢性激活的CD4+ T细胞的多组学分析确定了耗竭和代谢重编程的驱动因素。
PLoS Biol. 2024 Dec 17;22(12):e3002943. doi: 10.1371/journal.pbio.3002943. eCollection 2024 Dec.
10
B7-H3 in glioblastoma and beyond: significance and therapeutic strategies.胶质母细胞瘤及其他疾病中的B7-H3:意义与治疗策略
Front Immunol. 2024 Nov 25;15:1495283. doi: 10.3389/fimmu.2024.1495283. eCollection 2024.
髓样细胞样转录本2(TLT-2)上表达的触发受体是B7-H3的反受体,可增强T细胞反应。
Proc Natl Acad Sci U S A. 2008 Jul 29;105(30):10495-500. doi: 10.1073/pnas.0802423105. Epub 2008 Jul 23.
4
Interaction of human PD-L1 and B7-1.人程序性死亡配体1(PD-L1)与B7-1的相互作用
Mol Immunol. 2008 Aug;45(13):3567-72. doi: 10.1016/j.molimm.2008.05.014. Epub 2008 Jun 27.
5
Interactions of T cells with fibroblast-like synoviocytes: role of the B7 family costimulatory ligand B7-H3.T细胞与成纤维样滑膜细胞的相互作用:共刺激配体B7-H3在B7家族中的作用
J Immunol. 2008 Mar 1;180(5):2989-98. doi: 10.4049/jimmunol.180.5.2989.
6
B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome.B7-H3和B7x在人类前列腺癌中高表达,并与疾病扩散和不良预后相关。
Proc Natl Acad Sci U S A. 2007 Dec 4;104(49):19458-63. doi: 10.1073/pnas.0709802104. Epub 2007 Nov 27.
7
The Pfam protein families database.Pfam蛋白质家族数据库。
Nucleic Acids Res. 2008 Jan;36(Database issue):D281-8. doi: 10.1093/nar/gkm960. Epub 2007 Nov 26.
8
Identification of the scavenger receptors SREC-I, Cla-1 (SR-BI), and SR-AI as cellular receptors for Tamm-Horsfall protein.鉴定清道夫受体SREC-I、Cla-1(SR-BI)和SR-AI作为Tamm-Horsfall蛋白的细胞受体。
J Leukoc Biol. 2008 Jan;83(1):131-8. doi: 10.1189/jlb.0407231. Epub 2007 Oct 10.
9
B7-H3 ligand expression by prostate cancer: a novel marker of prognosis and potential target for therapy.前列腺癌中B7-H3配体的表达:一种新的预后标志物和潜在治疗靶点。
Cancer Res. 2007 Aug 15;67(16):7893-900. doi: 10.1158/0008-5472.CAN-07-1068. Epub 2007 Aug 8.
10
Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses.程序性死亡-1配体1与B7-1共刺激分子特异性相互作用,以抑制T细胞反应。
Immunity. 2007 Jul;27(1):111-22. doi: 10.1016/j.immuni.2007.05.016. Epub 2007 Jul 12.